• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nautilus Biotechnology Inc (NQ: NAUT )

2.600 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 2.600
Bid (Size) 2.600 (3)
Ask (Size) 2.850 (1)
Prev. Close 2.600
Today's Range 2.600 - 2.600
52wk Range 2.190 - 3.455
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
October 31, 2024
Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research’s esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging 
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
October 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire

Performance

YTD
-13.91%
-13.91%
1 Month
-3.70%
-3.70%
3 Month
+3.59%
+3.59%
6 Month
-2.62%
-2.62%
1 Year
+1.56%
+1.56%

More News

Read More
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
October 29, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
October 08, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
September 17, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 14, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024
July 30, 2024
Via InvestorPlace
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
July 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
July 09, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
May 23, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024
April 30, 2024
Via InvestorPlace
Nautilus Biotechnology Reports First Quarter 2024 Financial Results
April 30, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
April 11, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 29, 2024
Via Benzinga
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
February 22, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 07, 2024
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
November 30, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
November 17, 2023
Via Benzinga
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
November 01, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
October 31, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
October 11, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
September 28, 2023
Via Benzinga
Williams-Sonoma, ESS Tech And Other Big Stocks Moving Higher On Monday
September 25, 2023
Via Benzinga
Topics Stocks
Exposures US Equities
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
September 06, 2023
From Nautilus Biotechnology Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap